[Indicators of cellular immunity in patients with multiple sclerosis].
As many as 111 patients with multiple sclerosis were subjected to clinical and functional examinations twice: on admission to the hospital and after immunocorrective therapy. The patients were discovered to have alterations in cellular immunity. During exacerbation, there was a decline of suppressors and a rise of the content of B lymphocytes. The immunocorrective therapy led to immunodeficiency stabilization.